Introduction
• Urinary tract (UT) cytology is currently used to evaluate patients with hematuria or as a management tool for those with urothelial neoplasia.
• Often it is the first step for bladder carcinoma screening and diagnosis.
• The aim of this study is to investigate the performance characteristics of the UT specimens in the CAP NGC program over an 11 year period
Materials
• The study evaluated participant responses between 2000-2010 from the CAP NGC • Reference diagnosis:
-Positive for malignancy (including high-grade urothelial carcinoma (HGUC), squamous cell carcinoma (SqCC), or adenocarcinoma (ADC)) -Benign diagnoses (including entities such as Polyoma virus infection and ileal loop urine).
• 
Conclusion
• Urinary tract cytology preparations perform well in an interlaboratory comparison program.
• Liquid based preparations performed the best (compared to conventional and cytospin preparations).
• Diagnostic difficulties -subclassifying malignant cases -interpreting negative, ileal loop specimens, and Polyoma virus challenges as malignant.
